Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.40 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28360751 | 0.98 | CYP1A2 (0.50) | CYP1A2SIGMAR1CHRNB2CHRNA7CHRNA4 | |
| SCHEMBL3944360 | 0.98 | CYP1A2 (0.50) | CYP1A2SIGMAR1CHRNB2CHRNA7CHRNA4 | |
| SCHEMBL608793 | 0.98 | CYP1A2 (0.50) | CYP1A2SIGMAR1CHRNB2CHRNA7CHRNA4 | |
| SCHEMBL3938909 | 0.95 | — | — | |
| SCHEMBL23121455 | 0.91 | SIGMAR1 (0.50) | CYP1A2SIGMAR1CHRNB2CHRNA7CHRNA4 | |
| SCHEMBL29222354 | 0.91 | SIGMAR1 (0.50) | CYP1A2SIGMAR1CHRNB2CHRNA7CHRNA4 | |
| SCHEMBL7398026 | 0.91 | SIGMAR1 (0.50) | CYP1A2SIGMAR1CHRNB2CHRNA7CHRNA4 | |
| SCHEMBL6318571 | 0.91 | SIGMAR1 (0.50) | CYP1A2SIGMAR1CHRNB2CHRNA7CHRNA4 | |
| SCHEMBL3940022 | 0.90 | — | — | |
| SCHEMBL9801592 | 0.89 | SIGMAR1 (0.54) | CYP1A2SIGMAR1TSHREPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117916342-A | Heavy oligomer composition of selective 1-hexene and 1-octene catalyst | 切弗朗菲利浦化学公司 | 2024-04-19 | — | — | CN | claimed |
| CN-117916342-A | Heavy oligomer composition of selective 1-hexene and 1-octene catalyst | 切弗朗菲利浦化学公司 | 2024-04-19 | — | — | CN | disclosed |
| EP-2780026-B1 | HCV NS3 PROTEASE INHIBITORS | MERCK SHARP & DOHME (US) | 2019-10-23 | — | — | EP | disclosed |
| EP-3492464-A1 | INTERMEDIATES FOR PREPARING INHIBITORS OF HEPATITIS C VIRUS | Gilead Sciences, Inc. (US) | 2019-06-05 | — | — | EP | disclosed |
| EP-3159345-A1 | INHIBITORS OF HEPATITIS C VIRUS | Gilead Sciences, Inc. (US) | 2017-04-26 | — | — | EP | disclosed |
| US-20030207218-A1 | Silver salt photothermographic dry imaging material | KONICA CORPORATION (JP) | 2003-11-06 | — | — | US | disclosed |
| US-6475697-B2 | MULTILAYER; SUPPORT, SILVER HALIDE EMULSION, REDUCING AGENT, SUBBING AGENT AND BINDER | KONICA CORPORATION (JP) | 2002-11-05 | — | — | US | disclosed |
| US-20020015925-A1 | Image forming material | KONICA CORPORATION (JP) | 2002-02-07 | — | — | US | disclosed |
| US-20010038981-A1 | Photothermographic dry imaging material easy to separate emulsion layer from support and method for separation | KONICA CORPORATION (JP) | 2001-11-08 | — | — | US | disclosed |
| US-4287378-A | BY CATALYTIC DISPROPORTIONATION, PROPORTIONATION, OR ISOMERIZATION WHEREIN THE CATALYST IS A TRANSITION METAL OXIDE EXPOSED TO RADIATION | PHILLIPS PETROLEUM COMPANY (US) | 1981-09-01 | — | — | US | disclosed |